Victrex’s (VCT) “Buy” Rating Reaffirmed at Canaccord Genuity Group

Canaccord Genuity Group restated their buy rating on shares of Victrex (LON:VCT) in a report issued on Monday, MarketBeat Ratings reports. Canaccord Genuity Group currently has a GBX 725 price target on the stock.

Separately, JPMorgan Chase & Co. reduced their price target on shares of Victrex from GBX 725 to GBX 625 and set a “buy” rating on the stock in a research note on Wednesday, March 18th. Two research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of GBX 750.

Victrex Trading Down 0.7%

VCT stock opened at GBX 621 on Monday. The company has a market capitalization of £541.04 million, a PE ratio of 19.53, a P/E/G ratio of 1.92 and a beta of 0.75. Victrex has a 12 month low of GBX 515 and a 12 month high of GBX 935. The firm’s 50-day moving average is GBX 634.43 and its 200 day moving average is GBX 650.84. The company has a debt-to-equity ratio of 11.30, a current ratio of 3.01 and a quick ratio of 1.99.

About Victrex

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.